Usage: Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.
Usage: BASAGLAR® is indicated for improving glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.
Usage: BRENZAVVY is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not recommended for patients with type 1 diabetes mellitus.
Usage: Colesevelam hydrochloride tablets are indicated to reduce elevated LDL cholesterol in adults with primary hyperlipidemia and in boys/girls (10-17 years) with heterozygous familial hypercholesterolemia. Additionally, it is used to improve glycemic control in adults with type 2 diabetes mellitus, alongside diet and exercise.
Usage: Colesevelam hydrochloride tablets are indicated to reduce elevated LDL cholesterol in adults with primary hyperlipidemia and in boys/postmenarchal girls aged 10-17 with heterozygous familial hypercholesterolemia. Additionally, they improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.
Usage: Colesevelam hydrochloride is indicated as an adjunct to diet and exercise for reducing LDL cholesterol in adults with primary hyperlipidemia and in boys/girls aged 10-17 with heterozygous familial hypercholesterolemia. It also improves glycemic control in adults with type 2 diabetes mellitus. Not for type 1 diabetes or diabetic ketoacidosis.
Usage: CYCLOSET is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. It is not for type 1 diabetes or diabetic ketoacidosis, and its efficacy is limited when used with thiazolidinediones or insulin.
Usage: FARXIGA (dapagliflozin) is indicated for reducing risks associated with chronic kidney disease, heart failure, and for improving glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, alongside diet and exercise. It is not recommended for type 1 diabetes or specific kidney conditions.
Usage: Glimepiride tablets are indicated to improve glycemic control in adults with type 2 diabetes mellitus, used alongside diet and exercise. They are not intended for type 1 diabetes or diabetic ketoacidosis treatment.